Neoadjuvant chemotherapy versus primary debulking surgery in the treatment of advanced ovarian cancer: for and against

 

Authors

  • C. Zamagni Medical Oncology Unit, AOU Policlinico S. Orsola-Malpighi, Bologna, Italy.
  • S. Mahner Department of Gynecology and Gynecologic Oncology, University Medical Centre Hamburg-Eppendorf, Germany.
  • P. Harter Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Germany.
  • A. du Bois Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Germany.
  • D. Lorusso Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Abstract

No abstract available

Downloads

Published

2014-04-15

How to Cite

1.
Zamagni C, Mahner S, Harter P, du Bois A, Lorusso D. Neoadjuvant chemotherapy versus primary debulking surgery in the treatment of advanced ovarian cancer: for and against:  . CBN [Internet]. 2014 Apr. 15 [cited 2024 Nov. 23];2(1):12-5. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/258

Issue

Vol. 2 No. 1 (2014): April 2014

Section

Interview

License

Articles published in Cancer Breaking News are distributed under the CC Attribution-NonCommercial-NoDerivatives 4.0 license, which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.